Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

  1. Mackenzie, I.S.
  2. Ford, I.
  3. Nuki, G.
  4. Hallas, J.
  5. Hawkey, C.J.
  6. Webster, J.
  7. Ralston, S.H.
  8. Walters, M.
  9. Robertson, M.
  10. De Caterina, R.
  11. Findlay, E.
  12. Perez-Ruiz, F.
  13. McMurray, J.J.V.
  14. MacDonald, T.M.
  15. Aziz, J.
  16. Dobson, G.
  17. Doney, A.S.F.
  18. Flynn, R.W.V.
  19. Furnace, J.
  20. Grieve, J.W.K.
  21. Guthrie, G.
  22. Jamieson, D.
  23. Jennings, C.G.
  24. Kean, S.
  25. Lund, L.C.
  26. McConnachie, A.
  27. Pigazzani, F.
  28. Riches, P.L.
  29. Rix Hanson, M.
  30. Rogers, A.
  31. Rooke, E.D.M.
  32. Thomson, J.
  33. Warren, M.
  34. Wetherall, K.
  35. Wilson, R.
  36. Hall, C.P.
  37. Maseri, A.
  38. Bird, H.A.
  39. Murray, G.
  40. Dear, J.W.
  41. Petrie, M.
  42. MacDonald, M.
  43. Jhund, P.S.
  44. Connolly, E.
  45. Murphy, D.J.
  46. Paul, N.
  47. Olsson, A.
  48. Koskinen, P.T.
  49. Fuat, A.
  50. Foster, A.
  51. Saywood, W.
  52. Barr, R.J.
  53. McConnachie, L.
  54. Wilson, L.F.
  55. Larsen Rasmussen, L.
  56. McGinnis, A.R.
  57. Birrell, H.
  58. Keiller, M.
  59. Bremner, I.S.
  60. Forbes, G.J.
  61. Dumbleton, J.S.
  62. Rhodes, J.
  63. Waller, T.
  64. Montrer des auteurs +
Revue:
The Lancet

ISSN: 1474-547X 0140-6736

Année de publication: 2020

Volumen: 396

Número: 10264

Pages: 1745-1757

Type: Article

DOI: 10.1016/S0140-6736(20)32234-0 GOOGLE SCHOLAR

Objectifs de Développement Durable